372 related articles for article (PubMed ID: 9024661)
1. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.
Okubo Y; Suhara T; Suzuki K; Kobayashi K; Inoue O; Terasaki O; Someya Y; Sassa T; Sudo Y; Matsushima E; Iyo M; Tateno Y; Toru M
Nature; 1997 Feb; 385(6617):634-6. PubMed ID: 9024661
[TBL] [Abstract][Full Text] [Related]
2. [Distribution and function of dopamine D1, D2 receptor].
Suhara T; Miyoshi M
Rinsho Shinkeigaku; 2007 Nov; 47(11):826-8. PubMed ID: 18210808
[TBL] [Abstract][Full Text] [Related]
3. Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia.
Hirvonen J; van Erp TG; Huttunen J; Någren K; Huttunen M; Aalto S; Lönnqvist J; Kaprio J; Cannon TD; Hietala J
Psychiatry Res; 2006 Jan; 146(1):13-20. PubMed ID: 16361088
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural analysis of prefrontal cortical inputs to the rat amygdala: spatial relationships to presumed dopamine axons and D1 and D2 receptors.
Pinto A; Sesack SR
Brain Struct Funct; 2008 Sep; 213(1-2):159-75. PubMed ID: 18340460
[TBL] [Abstract][Full Text] [Related]
5. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
[TBL] [Abstract][Full Text] [Related]
6. Changes in cortical dopamine D1 receptor binding associated with cognitive training.
McNab F; Varrone A; Farde L; Jucaite A; Bystritsky P; Forssberg H; Klingberg T
Science; 2009 Feb; 323(5915):800-2. PubMed ID: 19197069
[TBL] [Abstract][Full Text] [Related]
7. Layer V neurons bear the majority of mRNAs encoding the five distinct dopamine receptor subtypes in the primate prefrontal cortex.
Lidow MS; Wang F; Cao Y; Goldman-Rakic PS
Synapse; 1998 Jan; 28(1):10-20. PubMed ID: 9414013
[TBL] [Abstract][Full Text] [Related]
8. Targeting prefrontal cortical dopamine D1 and N-methyl-D-aspartate receptor interactions in schizophrenia treatment.
Yang CR; Chen L
Neuroscientist; 2005 Oct; 11(5):452-70. PubMed ID: 16151046
[TBL] [Abstract][Full Text] [Related]
9. [The involvement of 5-HT1a serotonin receptors in the pathophysiology and pharmacotherapy of schizophrenia].
Maćkowiak M; Czyrak A; Wedzony K
Psychiatr Pol; 2000; 34(4):607-21. PubMed ID: 11059260
[TBL] [Abstract][Full Text] [Related]
10. Decreased binding of [11C]NNC112 and [11C]SCH23390 in patients with chronic schizophrenia.
Kosaka J; Takahashi H; Ito H; Takano A; Fujimura Y; Matsumoto R; Nozaki S; Yasuno F; Okubo Y; Kishimoto T; Suhara T
Life Sci; 2010 May; 86(21-22):814-8. PubMed ID: 20361984
[TBL] [Abstract][Full Text] [Related]
11. Cortical microcircuits in schizophrenia--the dopamine hypothesis revisited.
Winterer G
Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S68-71. PubMed ID: 16508900
[TBL] [Abstract][Full Text] [Related]
12. Seasonal relationships between dopamine D1 and D2 receptor and equine FSH receptor mRNA in equine ovarian epithelium.
King SS; Jones KL; Mullenix BA; Heath DT
Anim Reprod Sci; 2008 Oct; 108(1-2):259-66. PubMed ID: 17935915
[TBL] [Abstract][Full Text] [Related]
13. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.
Aubert I; Ghorayeb I; Normand E; Bloch B
J Comp Neurol; 2000 Feb; 418(1):22-32. PubMed ID: 10701753
[TBL] [Abstract][Full Text] [Related]
14. D1 dopamine receptors in the mouse prefrontal cortex: Immunocytochemical and cognitive neuropharmacological analyses.
Lidow MS; Koh PO; Arnsten AF
Synapse; 2003 Feb; 47(2):101-8. PubMed ID: 12454947
[TBL] [Abstract][Full Text] [Related]
15. Abnormal effective connectivity of dopamine D2 receptor binding in schizophrenia.
Yasuno F; Suhara T; Okubo Y; Ichimiya T; Takano A; Sudo Y; Inoue M
Psychiatry Res; 2005 Apr; 138(3):197-207. PubMed ID: 15854788
[TBL] [Abstract][Full Text] [Related]
16. Schizophrenia. An emerging pathophysiology.
Nestler EJ
Nature; 1997 Feb; 385(6617):578-9. PubMed ID: 9024651
[No Abstract] [Full Text] [Related]
17. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.
Gurevich EV; Joyce JN
Biol Psychiatry; 1997 Oct; 42(7):529-45. PubMed ID: 9376449
[TBL] [Abstract][Full Text] [Related]
19. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.
Williams GV; Goldman-Rakic PS
Nature; 1995 Aug; 376(6541):572-5. PubMed ID: 7637804
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of the D1 and D5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs.
Lidow MS; Elsworth JD; Goldman-Rakic PS
J Pharmacol Exp Ther; 1997 Apr; 281(1):597-603. PubMed ID: 9103549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
